Abstract: Esophageal Reconstruction with Supercharged Jejunal Interposition: A Reliable Intervention for Establishing Esophageal Continuity in a Pediatric Population

M oday, O cber 9, 2017 levels. 30.6% of patients had high aFXa levels, including 12.2% of the population who were therapeutically anti-coagulated. Patient weight predicted enoxaparin metabolism (r2value of 0.45). When compared to patients given enoxaparin 40mg once daily, patients given enoxaparin 40mg twice daily 1) were significantly less likely to have low aFXa (9.2% vs. 44.1%, p<0.001), 2) had nonsignificant increase in clinically relevant bleeding (6.1% vs. 3.2%%, p=0.34), and 3) had significantly fewer post-operative VTE (0% vs. 5.3% p=0.021).